BRAENDER LORI J 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 18, 2020
Insider Transaction Report
Form 4
BRAENDER LORI J
Chief Legal Officer
Transactions
- Purchase
Common Stock
2020-03-16$1.54/sh+14,000$21,624→ 25,000 total - Award
Non-Qualified Stock Option (right to buy)
2020-03-16+60,000→ 60,000 totalExercise: $1.54Exp: 2030-03-16→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple transactions with prices ranging from $1.46 to $1.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.